相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Artificial Intelligence in Pediatric Cardiology: A Scoping Review
Yashendra Sethi et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Identification and verification of immune-related biomarkers and immune infiltration in diabetic heart failure
Zuoquan Zhong et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
TNFR1 Contributes to Activation-Induced Cell Death of Pathological CD4+T Lymphocytes During Ischemic Heart Failure
Vinay Kumar et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2022)
CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction
Vinay Kumar et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
What will we ask to artificial intelligence for cardiovascular medicine in the next decade?
Guglielmo Gallone et al.
MINERVA CARDIOLOGY AND ANGIOLOGY (2022)
Precision Medicine, AI, and the Future of Personalized Health Care
Kevin B. Johnson et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Artificial Intelligence as a Business Partner in Cardiovascular Preci-sion Medicine: An Emerging Approach for Disease Detection and Treatment Optimization
Valeria Visco et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine
Ziwei Pan et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2021)
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo-DHF trial
Leanne Dumeny et al.
PHARMACOTHERAPY (2021)
Utilising biomarkers to predict right heart maladaptive phenotype: a step toward precision medicine
Soni Savai Pullamsetti et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Regulatory T Cells in Chronic Heart Failure
Yuzhi Lu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research-What We Have Learnt and Not Learnt until Now
Michael Simeon et al.
CELLS (2021)
Sex- and gender-specific precision medicine for chronic coronary syndromes: challenges and opportunities
Felicita Andreotti et al.
KARDIOLOGIA POLSKA (2021)
Trend analysis of disability adjusted life years due to cardiovascular diseases: results from the global burden of disease study 2019
Fatemeh Masaebi et al.
BMC PUBLIC HEALTH (2021)
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Joel G. Rurik et al.
CIRCULATION RESEARCH (2021)
Low serum albumin levels and in-hospital outcomes in patients with ST segment elevation myocardial infarction
Flavio Giuseppe Biccire et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Glutathione Infusion Before and 3 Days After Primary Angioplasty Blunts Ongoing NOX2-Mediated Inflammatory Response
Gaetano Tanzilli et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine
Samuele Ambrosini et al.
MINERVA CARDIOLOGY AND ANGIOLOGY (2021)
Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction
Zhanpeng Wen et al.
THERANOSTICS (2021)
CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction
Julio Nunez et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Computational and Pharmacogenomic Insights on Hypertension Treat-ment: Rational Drug Design and Optimization Strategies
Lakshmanan Loganathan et al.
CURRENT DRUG TARGETS (2020)
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
Pierpaolo Pellicori et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Artificial intelligence and the cardiologist: what you need to know for 2020
Antonio de Marvao et al.
HEART (2020)
Biomarkers in primary prevention Meaningful diagnosis based on biomarker scores?
Christian Schulte et al.
HERZ (2020)
Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases
Concetta Schiano et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
Sonia Shah et al.
NATURE COMMUNICATIONS (2020)
Design and Rationale of the ERA-CVD Consortium PREMED-CAD-Precision Medicine in Coronary Artery Disease
Apurva Shrivastava et al.
BIOMOLECULES (2020)
The protective role of bFGF in myocardial infarction and hypoxia cardiomyocytes by reducing oxidative stress via Nrf2
Gaozan Tong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Collaborative AI and Laboratory Medicine integration in precision cardiovascular medicine
Damien Gruson et al.
CLINICA CHIMICA ACTA (2020)
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial
Naveen L. Pereira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto et al.
LANCET (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Increasing the Precision of Hypertension Treatment Through Personalized Trials: a Pilot Study
Ian M. Kronish et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines
Yoshihiro Kokubo et al.
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2019)
Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection
Brooke N. Wolford et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
Plaque erosion: Towards precision medicine in acute coronary syndromes
Filippo Crea et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Daniel M. F. Claassens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers
Perry V. Halushka et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14 (2019)
Natural selection and local adaptation of blood pressure regulation and their perspectives on precision medicine in hypertension
Boon-Peng Hoh et al.
HEREDITAS (2019)
Advances in computational modelling for personalised medicine after myocardial infarction
Kenneth Mangion et al.
HEART (2018)
Omics, Big Data, and Precision Medicine in Cardiovascular Sciences
Edward Lau et al.
CIRCULATION RESEARCH (2018)
Emerging Role of Precision Medicine in Cardiovascular Disease
Jane A. Leopold et al.
CIRCULATION RESEARCH (2018)
Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
Diana M. Rydberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Artificial Intelligence in Cardiology
Kipp W. Johnson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Metabolic Biomarkers in Heart Failure
Chonyang L. Albert et al.
HEART FAILURE CLINICS (2018)
Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection
Marjolijn Renard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
Evangelos Evangelou et al.
NATURE GENETICS (2018)
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Mathew S. Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
MINOCA: current perspectives
Rocco A. Montone et al.
AGING-US (2018)
EPC Dysfunction and Immune Networks: Translating Opportunities for Clinical Setting in Personalized Medicine
Javier Rodriguez-Carrio et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Fernando Dominguez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The growing role of precision and personalized medicine for cancer treatment
Paulina Krzyszczyk et al.
TECHNOLOGY (2018)
Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine
M. Zaiou et al.
CLINICAL GENETICS (2017)
Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognosticmodels for cardiovascular events and bleeding in myocardial infarction survivors
Laura Pasea et al.
EUROPEAN HEART JOURNAL (2017)
Genomics and Precision Medicine for Clinicians and Scientists in Hypertension
Anna Dominiczak et al.
HYPERTENSION (2017)
Artificial Intelligence in Precision Cardiovascular Medicine
Chayakrit Krittanawong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Diagnostic value of brain natriuretic peptide and β-endorphin plasma concentration changes in patients with acute left heart failure and atrial fibrillation
Shao-Dan Feng et al.
MEDICINE (2017)
From GWAS to functional genomics-based precision medicine
David L. Mattson et al.
Nature Reviews Nephrology (2017)
Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses
Jenni M. Rimpela et al.
PHARMACOGENOMICS (2017)
Thymosin Beta-4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction
Chester L. Drum et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The Future of Cardiovascular Therapeutics
Calum A. MacRae et al.
CIRCULATION (2016)
Real-world data in the molecular erafinding the reality in the real world
D. J. Dickson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans
Yan Gong et al.
HYPERTENSION (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension
Praveen Surendran et al.
NATURE GENETICS (2016)
Precision medicine in cardiology
Elliott M. Antman et al.
NATURE REVIEWS CARDIOLOGY (2016)
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Robert A. Scott et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case
Farshid S. Garmaroudi et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
Wynn G. Hunter et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
New Evidences of Key Factors Involved in Silent Stones Etiopathogenesis and Trace Elements: Microscopic, Spectroscopic, and Biochemical Approach
Simona Cavalu et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2015)
Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study
G. Michael Felker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Copeptin (C-terminal pro Arginine-Vasopressin) is an Independent Long-Term Prognostic Marker in Heart Failure with Reduced Ejection Fraction
Zoltan Pozsonyi et al.
HEART LUNG AND CIRCULATION (2015)
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives
Martina Chittani et al.
JOURNAL OF HYPERTENSION (2015)
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization
Sayanti Bhattacharya et al.
ATHEROSCLEROSIS (2014)
G-Protein Receptor Kinase 4 Polymorphism and Response to Antihypertensive Therapy
Anne M. Muskalla et al.
CLINICAL CHEMISTRY (2014)
AT2 Receptors Targeting Cardiac Protection Post-Myocardial Infarction
Elena Kaschina et al.
CURRENT HYPERTENSION REPORTS (2014)
Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics
Bruce R. Korf et al.
GENETICS IN MEDICINE (2014)
Epoxyeicosatrienoic acids and cardioprotection: The road to translation
Akinyemi Oni-Orisan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure Refining the Gut Hypothesis
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A Second Dilemma in Cardiovascular Medicine Personalized Medicine Versus Personal Interaction With the Patient
Valentin Fuster
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
1H-NMR-Based Metabolic Analysis of Human Serum Reveals Novel Markers of Myocardial Energy Expenditure in Heart Failure Patients
Zhiyong Du et al.
PLOS ONE (2014)
Metabolomic Heterogeneity of Pulmonary Arterial Hypertension
Yidan Zhao et al.
PLOS ONE (2014)
miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?
Emeline Goretti et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Prevalence, Extent, and Independent Predictors of Silent Myocardial Infarction
Nisha Arenja et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review
Lizzy M. Brewster et al.
BMC MEDICINE (2013)
Immunity, atherosclerosis and cardiovascular disease
Johan Frostegard
BMC MEDICINE (2013)
Soluble Concentrations of the Interleukin Receptor Family Member ST2 and ß-Blocker Therapy in Chronic Heart Failure
Hanna K. Gaggin et al.
CIRCULATION-HEART FAILURE (2013)
Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, its Pathological Roles and Therapeutic Application
Toshio Nishikimi et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
Loci influencing blood pressure identified using a cardiovascular gene-centric array
Santhi K. Ganesh et al.
HUMAN MOLECULAR GENETICS (2013)
Effects of ACE and ADD1 gene polymorphisms on blood pressure response to hydrochlorothiazide: a meta-analysis
Hye Duck Choi et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure
Juan Wang et al.
MOLECULAR BIOSYSTEMS (2013)
Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression
Matteo Trudu et al.
NATURE MEDICINE (2013)
A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
Stephen E. Kimmel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Randomized Trial of Genotype-Guided Dosing of Warfarin
Munir Pirmohamed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
William R. Wikoff et al.
PLOS ONE (2013)
Metabonomics Analysis of Plasma Reveals the Lactate to Cholesterol Ratio as an Independent Prognostic Factor of Short-Term Mortality in Acute Heart Failure
Franck Desmoulin et al.
PLOS ONE (2013)
Long-Term Trajectory of Two Unique Cardiac Biomarkers and Subsequent Left Ventricular Structural Pathology and Risk of Incident Heart Failure in Community-Dwelling Older Adults at Low Baseline Risk
Danielle Glick et al.
JACC-HEART FAILURE (2013)
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea
Ravi V. Shah et al.
EUROPEAN HEART JOURNAL (2012)
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
Natalia Lopez-Andres et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support
Sjoukje I. Lok et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis
Andrea L. Jorgensen et al.
PLOS ONE (2012)
Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
Tariq Ahmad et al.
NATURE REVIEWS CARDIOLOGY (2011)
Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C→T polymorphism in MTHFR
Geraldine Horigan et al.
JOURNAL OF HYPERTENSION (2010)
Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin. Part 1: Experimental Studies
Mara Ferrandi et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Plasma Renin Test-Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial
Brent M. Egan et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
Jean-Philippe Collet et al.
LANCET (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
Stephen T. Turner et al.
HYPERTENSION (2008)
β1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension
Jie Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 Transgenic IAb knockout nonobese diabetic mice
Sarah L. Hayward et al.
JOURNAL OF IMMUNOLOGY (2006)
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment - The genetics of hypertension-associated treatment (GenHAT) study
DK Arnett et al.
CIRCULATION (2005)
Plasma renin activity levels in hypertensive persons: Their wide range and lack of suppression in diabetic and in most elderly patients
MH Alderman et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
EPR study of non-covalent spin labeled serum albumin and hemoglobin
S Cavalu et al.
BIOPHYSICAL CHEMISTRY (2002)
分享论文
